Current Vascular Pharmacology
Title: Editorial [ Has the Time Come for a New Definition of Microalbuminuria? ]
Volume: 6 Issue: 2
Author(s): Asterios Karagiannis, Dimitri P. Mikhailidis, Konstantinos Tziomalos, Anna I. Kakafika and Vasilios G. Athyros
Affiliation:
Export Options
About this article
Cite this article as:
Karagiannis Asterios, Mikhailidis P. Dimitri, Tziomalos Konstantinos, Kakafika I. Anna and Athyros G. Vasilios, Editorial [ Has the Time Come for a New Definition of Microalbuminuria? ], Current Vascular Pharmacology 2008; 6 (2) . https://dx.doi.org/10.2174/157016108783955329
DOI https://dx.doi.org/10.2174/157016108783955329 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroimmunomodulation and Aging: A Role for Transferrin and the Hypothalamus/Thymus Axis
Current Aging Science Cardiac Workup of Ischemic Stroke
Current Cardiology Reviews Targeted Enzyme Prodrug Therapies
Mini-Reviews in Medicinal Chemistry EDITORIAL [Hot Topic-II: PPAR Ligands and Cardiovascular Disorders: Friend or Foe (Guest Editors: Pitchai Balakumar and Gowraganahalli Jagadeesh)]
Current Molecular Pharmacology Proteomic Analysis of Endothelin-1 Targets in the Regulation of Cardiomyocyte Proliferation
Current Topics in Medicinal Chemistry The Vernakalant Story: How Did It Come to Approval in Europe and What is the Delay in the U.S.A?
Current Cardiology Reviews Targeting Adenosine Signaling to Treatment of Diabetic Nephropathy
Current Drug Targets Protein-mediated Fatty Acid Uptake in the Heart
Current Cardiology Reviews P2X7 Receptors: Channels, Pores and More
CNS & Neurological Disorders - Drug Targets Inflammatory Systemic Biomarkers in Setting Acute Coronary Syndromes - Effects of the Diurnal Variation
Current Drug Targets Metabolomics and Heart Diseases: From Basic to Clinical Approach
Current Medicinal Chemistry The Role of Apelins in the Physiology of the Heart
Protein & Peptide Letters Cysteine Network (CYSTEINET) Dysregulation in Parkinson’s Disease: Role of N-acetylcysteine
Current Drug Metabolism Ultrasound Contrast Agents: Updated Data on Safety Profile
Current Pharmaceutical Design Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews Tobacco Smoking and Association between Betel Nut Chewing and Metabolic Abnormalities Among Military Males: The CHIEF Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Cardiovascular Effects of Methotrexate in Rheumatoid Arthritis Revisited
Current Medicinal Chemistry Evolution of Biomarker Guided Therapy for Heart Failure: Current Concepts and Trial Evidence
Current Cardiology Reviews Short- and Long-Term Survival of Nonsurgical Intensive Care Patients and its Relation to Diagnosis, Severity of Disease, Age and Comorbidities
Current Aging Science The First Line of Defense Against Cardiac Hypertrophy
Current Molecular Medicine